FindTrial
Sign In

â??A STUDY TO COMPARE BETWEEN NALBUPHINE AND BUTORPHANOL AS ADJUVANTS TO ISOBARIC ROPIVACAINE WHEN INJECTED INTO THE SUB ARACHNOID SPACE IN ELECTIVE LOWER LIMB ORTHOPEDIC SURGERIESâ??

â??A Comprative study between INTRATHECAL NALBUPHINE AND BUTORPHANOL AS ADJUVANTS TO ISOBARIC ROPIVACAINE IN elective lower limb ORTHOPEDIC SURGERIESâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041268
Enrollment
60
Registered
2022-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: Nil Control Intervention1: Nalbuphine: Nalbuphine is a synthetic opioid , agonist-antagonist analgesic of phenanthrene series. It is chemically related Naloxone and Oxymorphone.It

Sponsors

Dr Sapna N Goud
Lead Sponsor
Dr Sapna N Goud
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I or II patients BMI less than 25

Exclusion criteria

Exclusion criteria: 1.Patients with known allergies to the study drugs. 2. Patients contraindicated for spinal anaesthesia 3. Patients posted for emergency procedures.

Design outcomes

Primary

MeasureTime frame
1. To compare the duration of analgesia and post operative analgesic effects of the drugs under study. 2. To compare the sensory and motor blockade and the recovery with the drugs under study. 3. To study the adverse effects of the drugs under studyTimepoint: At 5,10,15,20,25,30,35,40,45,50,55,60 minutes of drug injection After post operatives every 2 hours up to 48 hours—

Secondary

MeasureTime frame
To Study any Adverse effects of Drugs in Post-Operative PeriodTimepoint: From the time of Injection to 24Hours of time—

Countries

India

Contacts

Public ContactDr GURULINGAPPA A PATIL

Basaveshwar Teaching and General Hospital

dr.gurupatil@gmail.com9481002895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026